Margaret T Nguyen - JoVE Visualize

Showing results (1-10 of 5) with videos related to

Pageof 1

Sort By:

Bioorganic & Medicinal Chemistry Letters|October 24, 2009

Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitorsFabien Vincent, Margaret T Nguyen, Daniel E Emerling, et al.

Protein Expression and Purification|July 4, 2006

Expression and characterization of recombinant gamma-tryptaseJing Yuan, Jeri Beltman, Erik Gjerstad, et al.

Biochemical and Biophysical Research Communications|September 10, 2009

Identification and characterization of novel TRPV4 modulatorsFabien Vincent, Alejandra Acevedo, Margaret T Nguyen, et al.

Bioorganic & Medicinal Chemistry Letters|August 4, 2015

Identification of orally-bioavailable antagonists of the TRPV4 ion-channelZhi-Liang Wei, Margaret T Nguyen, Donogh J R O'Mahony, et al.

Cancer Immunology Research|October 12, 2021

Conditional PD-1/PD-L1 Probody Therapeutics Induce Comparable Antitumor Immunity but Reduced Systemic Toxicity Compared with Traditional Anti-PD-1/PD-L1 AgentsHikmat H Assi, Chihunt Wong, Kimberly A Tipton, et al.

Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:

Pageof 1

Bioorganic & Medicinal Chemistry Letters|October 24, 2009

Mining biologically-active molecules for inhibitors of fatty acid amide hydrolase (FAAH): identification of phenmedipham and amperozide as FAAH inhibitorsFabien Vincent, Margaret T Nguyen, Daniel E Emerling, et al.

Protein Expression and Purification|July 4, 2006

Expression and characterization of recombinant gamma-tryptaseJing Yuan, Jeri Beltman, Erik Gjerstad, et al.

Biochemical and Biophysical Research Communications|September 10, 2009

Identification and characterization of novel TRPV4 modulatorsFabien Vincent, Alejandra Acevedo, Margaret T Nguyen, et al.

Bioorganic & Medicinal Chemistry Letters|August 4, 2015

Identification of orally-bioavailable antagonists of the TRPV4 ion-channelZhi-Liang Wei, Margaret T Nguyen, Donogh J R O'Mahony, et al.

Cancer Immunology Research|October 12, 2021

Conditional PD-1/PD-L1 Probody Therapeutics Induce Comparable Antitumor Immunity but Reduced Systemic Toxicity Compared with Traditional Anti-PD-1/PD-L1 AgentsHikmat H Assi, Chihunt Wong, Kimberly A Tipton, et al.

Pageof 1